ClearPoint Neuro ROE 2010-2025 | CLPT
Current and historical return on equity (ROE) values for ClearPoint Neuro (CLPT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| ClearPoint Neuro ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-06-30 | $-0.02B | $0.02B | -93.62% |
| 2025-03-31 | $-0.02B | $0.02B | -75.47% |
| 2024-12-31 | $-0.02B | $0.03B | -59.50% |
| 2024-09-30 | $-0.02B | $0.03B | -61.54% |
| 2024-06-30 | $-0.02B | $0.03B | -64.29% |
| 2024-03-31 | $-0.02B | $0.04B | -78.50% |
| 2023-12-31 | $-0.02B | $0.02B | -87.62% |
| 2023-09-30 | $-0.02B | $0.02B | -72.73% |
| 2023-06-30 | $-0.02B | $0.03B | -61.31% |
| 2023-03-31 | $-0.02B | $0.03B | -47.06% |
| 2022-12-31 | $-0.02B | $0.04B | -38.55% |
| 2022-09-30 | $-0.02B | $0.04B | -35.96% |
| 2022-06-30 | $-0.02B | $0.04B | -35.16% |
| 2022-03-31 | $-0.02B | $0.05B | -34.22% |
| 2021-12-31 | $-0.02B | $0.05B | -32.43% |
| 2021-09-30 | $-0.01B | $0.04B | -37.68% |
| 2021-06-30 | $-0.01B | $0.05B | -42.55% |
| 2021-03-31 | $-0.01B | $0.04B | -68.09% |
| 2020-12-31 | $-0.01B | $0.00B | -466.67% |
| 2020-09-30 | $-0.01B | $0.00B | -311.11% |
| 2020-06-30 | $-0.01B | $0.00B | -186.67% |
| 2020-03-31 | $-0.01B | $0.00B | -133.33% |
| 2019-12-31 | $-0.01B | $0.01B | -133.33% |
| 2019-09-30 | $-0.01B | $0.01B | -133.33% |
| 2019-06-30 | $-0.01B | $0.01B | -181.82% |
| 2019-03-31 | $-0.01B | $0.00B | -250.00% |
| 2018-12-31 | $-0.01B | $0.00B | -184.62% |
| 2018-09-30 | $-0.01B | $0.00B | -164.71% |
| 2018-06-30 | $-0.01B | $0.00B | -127.27% |
| 2018-03-31 | $-0.01B | $0.01B | -103.70% |
| 2017-12-31 | $-0.01B | $0.01B | -140.00% |
| 2017-09-30 | $-0.01B | $0.01B | -215.38% |
| 2017-06-30 | $-0.01B | $0.01B | -514.29% |
| 2017-03-31 | $-0.01B | $0.00B | 600.00% |
| 2016-12-31 | $-0.01B | $0.00B | 450.00% |
| 2016-09-30 | $-0.01B | $0.00B | 355.56% |
| 2016-06-30 | $-0.01B | $0.00B | 125.00% |
| 2016-03-31 | $-0.01B | $0.00B | 133.33% |
| 2015-12-31 | $-0.01B | $0.00B | 177.78% |
| 2015-09-30 | $-0.01B | $-0.01B | 225.00% |
| 2015-06-30 | $-0.01B | $-0.01B | 288.89% |
| 2015-03-31 | $-0.01B | $0.00B | 282.35% |
| 2014-12-31 | $-0.01B | $0.00B | 125.00% |
| 2014-09-30 | $-0.01B | $-0.01B | 86.96% |
| 2014-06-30 | $0.00B | $-0.01B | 76.19% |
| 2014-03-31 | $0.00B | $0.00B | 63.16% |
| 2013-12-31 | $-0.01B | $-0.01B | 155.56% |
| 2013-09-30 | $0.00B | $-0.01B | 84.21% |
| 2013-06-30 | $0.00B | $0.00B | 84.21% |
| 2013-03-31 | $0.00B | $0.00B | 59.26% |
| 2012-12-31 | $-0.01B | $-0.01B | 63.16% |
| 2012-09-30 | $-0.01B | $-0.01B | 69.23% |
| 2012-06-30 | $-0.01B | $-0.01B | 69.57% |
| 2012-03-31 | $-0.01B | $-0.01B | 102.86% |
| 2011-12-31 | $-0.01B | $-0.02B | 145.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.298B | $0.031B |
| ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $186.057B | 22.51 |
| Intuitive Surgical (ISRG) | United States | $169.665B | 70.33 |
| IDEXX Laboratories (IDXX) | United States | $51.770B | 53.88 |
| Edwards Lifesciences (EW) | United States | $47.755B | 31.65 |
| Alcon (ALC) | Switzerland | $39.366B | 26.43 |
| IQVIA Holdings (IQV) | United States | $32.438B | 18.33 |
| DexCom (DXCM) | United States | $29.545B | 44.32 |
| Mettler-Toledo (MTD) | United States | $26.800B | 31.81 |
| STERIS (STE) | Ireland | $24.136B | 25.69 |
| Waters (WAT) | United States | $17.964B | 24.68 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.399B | 0.00 |
| Hologic (HOLX) | United States | $14.929B | 16.17 |
| Penumbra (PEN) | United States | $10.633B | 77.68 |
| Globus Medical (GMED) | United States | $8.275B | 19.09 |
| Sysmex ADR (SSMXY) | Japan | $7.913B | 25.14 |
| Masimo (MASI) | United States | $7.590B | 25.54 |
| Teleflex (TFX) | United States | $5.586B | 9.02 |
| Glaukos (GKOS) | United States | $5.495B | 0.00 |
| TransMedics (TMDX) | United States | $3.919B | 59.56 |
| Integer Holdings (ITGR) | United States | $3.779B | 18.86 |
| LivaNova (LIVN) | United Kingdom | $3.078B | 17.62 |
| Veracyte (VCYT) | United States | $2.387B | 32.98 |
| Alphatec Holdings (ATEC) | United States | $2.353B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.235B | 0.00 |
| Artivion (AORT) | United States | $2.073B | 104.60 |
| Nihon Kohden (NHNKY) | Japan | $1.992B | 23.78 |
| Elekta AB (EKTAY) | Sweden | $1.815B | 17.59 |
| Integra LifeSciences Holdings (IART) | United States | $1.179B | 6.75 |
| OPKO Health (OPK) | United States | $1.095B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.046B | 0.00 |
| IRadimed (IRMD) | United States | $0.921B | 44.72 |
| Tandem Diabetes Care (TNDM) | United States | $0.845B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.819B | 0.00 |
| AxoGen (AXGN) | United States | $0.743B | 0.00 |
| SiBone (SIBN) | United States | $0.719B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.592B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.554B | 9.79 |
| OrthoPediatrics (KIDS) | United States | $0.536B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.464B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.439B | 3.52 |
| AngioDynamics (ANGO) | United States | $0.417B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.385B | 91.83 |
| Mesa Laboratories (MLAB) | United States | $0.373B | 9.48 |
| RxSight (RXST) | United States | $0.370B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.309B | 0.00 |
| NeuroPace (NPCE) | United States | $0.303B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.297B | 20.48 |
| Alpha Tau Medical (DRTS) | Israel | $0.290B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.236B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| Neuronetics (STIM) | United States | $0.220B | 0.00 |
| Inogen (INGN) | United States | $0.216B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| CVRx (CVRX) | United States | $0.205B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.171B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.150B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.137B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.107B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.088B | 0.00 | |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.60 |